Clinical Trial Update: Use of Pyrvinium to Reverse Stomach Precancerous Conditions [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pyrvinium to reverse stomach precancerous conditions, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Pyrvinium (pyrvinium)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: STOMACH NEOPLASM | Phase 2 | Status: NOT_YET_RECRUITING